Infections associated with monoclonal antibody and fusion protein therapy in humans

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment

(2012) Teresa A Simon et al.   ARTHRITIS RESEARCH & THERAPY

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

(2010) D. Vassilopoulos et al.   ANNALS OF THE RHEUMATIC DISEASES

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

(2010) J. L. Nam et al.   ANNALS OF THE RHEUMATIC DISEASES

New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies

(2010) Tadeusz Robak et al.   BIODRUGS

Progressive Multifocal Leukoencephalopathy and Newer Biological Agents

(2010) Joseph R. Berger   DRUG SAFETY

Co-Stimulation Blockade as a New Strategy in Kidney Transplantation

(2010) Renaud Snanoudj et al.   DRUGS

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Monoclonal antibody therapy in multiple sclerosis

(2010) Paulo Fontoura   mAbs

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

(2010) J. B. Galloway et al.   RHEUMATOLOGY

Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte Globulin

(2010) K.S. Reddy et al.   TRANSPLANTATION PROCEEDINGS

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

(2009) N. Kamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Roles of B lymphocytes in multiple sclerosis: diversifying beyond the antibody response

(2009) Paulo Fontoura   Immunotherapy

Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-  Blocker in the Treatment of Rheumatic Diseases

(2009) Y. J. KIM et al.   JOURNAL OF RHEUMATOLOGY

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

(2009) A Österborg et al.   LEUKEMIA